Comprehensive Panel from Joi + Blokes

At $699 list price, the panel bundles unusually broad coverage with a 60-minute clinician consultation and a biological-age report. Value is weakened by the high upfront cost, location-dependent collection fees, promotional pricing that can change, the absence of public method-level performance detail, and the possibility that a narrower panel would answer a focused question with less cost and less incidental information. Fresh review 2026-09-15 confirms the provisional treatment: the same product page states both a $99 mobile-phlebotomy option (NY, NJ, RI where the address is serviceable) and a $100 in-home draw upgrade fee, routes lab collection to Quest or BioReference (NY/NJ), and shows no fixed checkout price on-page. Delivered cost stays provisional until the route and address are selected.

Joi + Blokes documents 110 biomarkers across metabolic and lipid markers, blood and oxygen transfer, hormones, thyroid, inflammation, liver, kidney and urinalysis, electrolytes, nutrients, and sex-specific health groups. Coverage is unusually broad for one panel, but the exact list varies by women or men route and broad count alone does not show depth, method, or clinically useful coverage for every concern. Fresh review 2026-09-15: the canonical product page presents the women's route variant (110 biomarkers, progesterone included, menstrual-cycle timing guidance, no PSA), and the site serves sex-specific route pages (e.g. /shop/women/diagnostic-labs/) carrying route-specific biomarker lists. Resolution applied: this record is treated as a product family with route-specific scope, not one universal list; the marker set must be read from the selected route's page.

The panel directly covers broad metabolic, cardiovascular, hormone, thyroid, inflammation, nutrient, kidney, liver, and blood-health goals, with biological age as a derived report output. Sex-specific routes affect the exact marker set, and the panel should not be represented as a direct test for environmental exposures, food reactions, pathogens, or every symptom or disease named in provider marketing.

The provider supplies portal results, a derived biological-age output, and an included 60-minute clinician consultation to review results and next steps. Interpretation still depends on the ordering route, reference ranges, medication timing, cycle context, and clinician judgment. The panel does not turn a broad collection of markers into a diagnosis or prove that an abnormal result caused a symptom.

The official page names a broad set of conventional blood, urine, hormone, thyroid, inflammation, lipid, nutrient, and organ-function measures. It identifies the marker groups but does not publish a product-specific analytical performance table, laboratory validation package, or method detail for every analyte, so measurement confidence is solid but not exceptional.

The panel can be purchased online and paired with a local lab visit or an optional in-home draw, followed by clinician review. The user must complete health and scheduling steps, fast before collection, verify address serviceability, and account for location-dependent pricing and collection options. The provider's 7 to 14 day estimate covers lab processing rather than the entire purchase-to-consult timeline. Fresh review 2026-09-15: draw fees ($99 vs $100 wordings on the same page), lab assignment (Quest vs BioReference for NY/NJ), and mobile-draw vs at-home-kit availability all depend on the entered address and selected route; access figures stay provisional.

Joi + Blokes provides a dedicated privacy portal and consumer privacy-choice route, which is better than having no public privacy path. The reviewed materials did not establish product-specific retention, specimen destruction, raw laboratory-result deletion, or a complete current map of laboratory, clinician, analytics, marketing, and treatment-related data handling, so privacy confidence remains deliberately conservative.

The exact product page publishes the 110-marker count, $699 list price, annual purchase options, 60-minute consultation, marker groups, collection workflow, preparation instructions, 7 to 14 day typical processing estimate, HSA or FSA route, and location-specific access notes. Transparency is reduced because the product family has sex-specific routes, promotional prices appear on other pages, and a complete state eligibility table is not public. Fresh review 2026-09-15 confirms the product-family structure: route-specific pages carry route-specific marker lists (the women's route shows progesterone and cycle guidance); no single universal marker list is published.